Virtu KCG Holdings’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Virtu KCG Holdings’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-333,347	Closed	-$5.65M	–	4453
2014 Q4	$5.65M	Sell	333,347 -123,043	-27%	-$1.73M	0.09%	122
2014 Q3	$5.44M	Buy	456,390 +426,589	+1,431%	+$2.91M	0.1%	129
2014 Q2	$168K	Buy	29,801 +17,063	+134%	+$78.6K	﹤0.01%	3137
2014 Q1	$47K	Sell	12,738 -9,061	-42%	-$34.5K	﹤0.01%	3343
2013 Q4	$73K	Sell	21,799 -12,260	-36%	-$50.6K	﹤0.01%	3527
2013 Q3	$144K	Buy	+34,059	New	+$161K	﹤0.01%	3263

Virtu KCG Holdings's AVNR Position: Q1 2015 in Review

Virtu KCG Holdings sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 333,347 shares — an estimated $5.65M sold.

Virtu KCG Holdings first reported a position in AVNR in Q3 2013 and held it in 6 quarters. The position peaked at $5.65M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Virtu KCG Holdings reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Virtu KCG Holdings sold 333,347 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $5.65M.
Virtu KCG Holdings first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 6 quarters.
Virtu KCG Holdings's AVANIR PHARMACEUTICALS, INC CL A position peaked at $5.65M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Virtu KCG Holdings's 13F filing for Q1 2015, filed 15 May 2015.